baber/WOPTO huggingface dataset:
Patent DK-1815028-T3 (DK)
Inventor: ADAMS THOMAS
IPC: C12N5/071
Filed: 2005-11-03
Granted: 2012-01-30
Abstract: The present invention relates to methods, compositions and kits for affinity isolation, affinity purification and affinity assay based on microbubbles coated with an affinity molecule. Particularly, the invention provides protein microbubbles coated with an affinity molecule. In addition, the invention provides glass microbubbles coated with an affinity molecule. Methods of using the microbubbles of the invention for isolating analytes and cells are specifically provided.
Patent DK-1966579-T3 (DK)
Inventor: MAYRHOFER NORBERT
IPC: G01L23/00
Filed: 2006-12-21
Granted: 2010-06-07
Abstract: The invention relates to an apparatus for measuring the cylinder internal pressure of internal combustion engines and, in particular, of gas engines, said apparatus having a first valve (5) which opens into the cylinder interior space, a measurement chamber (6) which can be connected to the cylinder interior space (1a) and can be disconnected from the latter by means of the first valve (5), and a pressure sensor (8) which is arranged in the region of the measurement chamber (6) in order to measure the pressure in the cylinder interior space when the first valve (5) is open. Permanent operation without thermal overload is enabled in such a way that at least one second valve (13) is provided in the region of the measurement chamber (6), said second valve being able to be changed to a closed position at least when the first valve (5) is open in order to seal off the measurement chamber (6) towards the outside.
Patent DK-2020008-T3 (DK)
Inventor: WASCHK VOLKER
IPC: H01B9/02
Filed: 2007-04-11
Granted: 2009-11-02
Abstract: The invention relates to a container for screening magnetic fields of low frequency, wherein the container may be provided in particular for accommodating electrical apparatuses or component parts. The invention proposes a container which comprises at least one inner container consisting of insulating material and an outer container consisting of insulating material. The space between the inner container and the outer container is filled with a ferromagnetic material layer having a high magnetic permeability, and the outer container is supported with respect to the inner container(s) by spacer elements. Preferably, the container is tubular, in particular cylindrical. Particularly strong sources of magnetic fields having a low frequency are electrical cables and lines. The invention therefore also proposes a use for laying electrical supply lines, preferably medium-voltage and high-voltage cables.
Patent DK-2217329-T3 (DK)
Inventor: JOHNSON KRISTINE ERIKSON
IPC: A61P43/00
Filed: 2008-11-07
Granted: 2018-04-23
Abstract: The present invention provides umbilical cord blood comprising placental stem cells for use in a method of treating a respiratory disorder or condition in a premature infant, wherein said placental stem cells comprise cells that are CD34 - , CD73 + , CD105 + , and CD200 + .
Patent DK-2264801-T3 (DK)
Inventor: KORNBLUH ROY
IPC: H01L41/113
Filed: 2000-07-20
Granted: 2013-01-07
Abstract: Electroactive polymers that are pre-strained to improve conversion from electrical to mechanical energy are disclosed. When a voltage is applied to electrodes contacting a pre-strained polymer, the polymer deflects. This deflection may be used to do mechanical work. The pre-strain improves the mechanical response of an electroactive polymer. Furthermore, actuators including an electroactive polymer and mechanical coupling to convert deflection of the polymer into mechanical work are disclosed. Compliant electrodes that conform to the shape of a polymer are also disclosed. Methods for fabricating electromechanical devices including one or more electroactive polymers are provided.
Patent DK-2594640-T3 (DK)
Title: Induction of exon skipping in eukaryotic cells
Inventor: VAN OMMEN GARRIT-JAN BOUDEWIJN
IPC: A61K48/00
Filed: 2001-09-21
Granted: 2016-03-21
Abstract: The present invention provides a method for at least in part decreasing the production of an aberrant protein in a cell, said cell comprising pre-mRNA comprising exons coding for said protein, by inducing so-called exon skipping in said cell. Exon-skipping results in mature mRNA that does not contain the skipped exon which leads to an altered product if said exon codes for amino acids. Exon skipping is performed by providing a cell with an agent capable of specifically inhibiting an exon inclusion signal, for instance an exon recognition sequence, of said exon. Said exon inclusion signal can be interfered with by a nucleic acid comprising complementarity to a part of said exon. Said nucleic acid, which is also herewith provided, can be used for the preparation of a medicament, for instance for the treatment of an inherited disease.
Patent DK-3090199-T3 (DK)
Inventor: CHAISE ALBIN
IPC: F17C11/00
Filed: 2014-12-23
Granted: 2018-05-28
Abstract: A reversible H2 storage system includes: a hydrogen storage tank including an enclosure containing metal hydrides incorporated into a heat exchanger having two fluid circuits, referred to as the primary exchanger, a hydrogen circulation circuit, referred to as the first circuit, linked to the inside of the enclosure, to supply or recover the H2 respectively to be absorbed or desorbed by the metal hydrides, the part of the first circuit inside the enclosure forming one of the exchanger circuits, a circuit for the circulation of a heat-transfer fluid, referred to as the second circuit, linked to the exchanger, the part of the second circuit in the exchanger forming the other of the circuits of the exchanger, the first and second circuits being sealed relative to each other, a pressurising device for bringing the pressure value in the second circuit to a value close to that in the first circuit.
Patent DK-2999476-T3 (DK)
Inventor: WARE ROY WENDELL
IPC: C07F9/6512
Filed: 2014-10-10
Granted: 2018-09-03
Abstract: The disclosure describes methods of synthesis of phosphonate ester compounds. The methods according to the disclosure allow for large-scale preparation of phosphonate ester compounds having high purity and stability. Also disclosed are morphic forms of phosphonate ester compounds.
Patent DK-2966091-T3 (DK)
Inventor: BANCHEREAU JACQUES F
IPC: C07K19/00
Filed: 2009-07-16
Granted: 2018-07-30
Abstract: The present invention includes compositions and methods for making and using a vaccine that includes a DC-specific antibody or fragment thereof to which an engineered Gag antigen is attached to form an antibody-antigen complex, wherein the Gag antigen is less susceptible to proteolytic degradation by eliminating one or more proteolytic sites or a DC-specific antibody or fragment thereof to which an engineered Nef antigen is attached to form an antibody-antigen complex, wherein the Nef antigen comprises one or more codon usage optimization that increase antibody-antigen complex secretion, or both, wherein the vaccine is able to elicit an HIV-specific T cell immune response to Gag p17, Gag p24, Nef and/or Cy clin D1.
Patent DK-3136889-T3 (DK)
Inventor: HOLZHERR RAPHAËL
IPC: A24F40/90
Filed: 2015-04-24
Granted: 2018-04-16
Abstract: The present invention relates to a method of controlling an electrically heated aerosol-generating system. The electrically heated aerosol-generating system comprises a charging device comprising a rechargeable power supply, and an electrically heated aerosol-generating device configured to receive an aerosol-generating substrate comprising a rechargeable power supply, and at least one electrical heating element. The method comprises: monitoring the ambient temperature adjacent the charging device; determining a charging current, for charging the rechargeable power supply of the charging device, in dependence on the ambient temperature; and charging the rechargeable power supply of the charging device at the determined charging current. The invention further relates to a system and device for carrying out the method.
Patent DK-0386903-T3 (DK)
Inventor: BENNETT CHRISTOPHER JOHN
IPC: H04H60/42
Filed: 1990-02-20
Granted: 1995-07-10
Abstract: A control system and a corresponding method for controlling descrambling within a plurality of jurisdictions of scrambled programs broadcast from at least one of said jurisdictions. The control system includes a descrambler authorization system (10) for each jurisdiction for providing authorization messages indicating whether descrambling of a predetermined program by descramblers (14) located within the respective jurisdiction of the descrambler authorization system is authorized; means (16) for distributing to a broadcast system (12) the authorization messages pertaining to said predetermined program that are provided by the descrambler authorization systems (10) for a plurality of said jurisdictions; a broadcast system (12) for broadcasting a scrambled predetermined program and the distributed authorization messages pertaining to said predetermined program that are provided by the descrambler authorization systems (10) for a plurality of said jurisdictions; and descramblers (14) located in each jurisdiction for descrambling the scrambled predetermined program only when authorized by said broadcast authorization messages provided by the descrambler authorization system (10) for the jurisdiction in which the descramblers are located. In order to enable a given jurisdiction to also regulate the export of scrambled programs by controlling the authorization of descramblers (14) located in other jurisdictions for descrambling of programs broadcast from the given jurisdiction, the broadcast system (12) includes means for also broadcasting a jurisdiction indication signal indicating the jurisdictions in which descrambling of the broadcast scrambled program is authorized; and the descramblers (14) include means for processing the jurisdiction indication signal and for enabling descrambling of said predetermined program only when the jurisdiction indication signal indicates that descrambling of said program is authorized in the jurisdiction in which the descramblers are located.
Patent DK-0587554-T3 (DK)
Inventor: LEANDER KURT
IPC: A61K9/107
Filed: 1990-07-17
Granted: 1997-10-27
Abstract: The invention refers to new pharmaceutical preparations for the treatment of psoriasis and condyloma acuminata, and containing podophyllotoxin in combination with a liquid triglyceride.
Patent DK-0456074-T3 (DK)
Inventor: SCHELL LONI DIPL-CHEM
IPC: C09K23/42
Filed: 1991-04-29
Granted: 1995-08-28
Abstract: The invention relates to a fountain solution or fountain solution concentrate for use in offset printing. The ready-for-use product contains 0.001 to 0.08% by weight of at least one alkanol or alkenol or of an alkanediol or alkenediol having 5 to 15 carbon atoms, which has been converted with ethylene oxide and/or propylene oxide into polyether structures having 3 to 12 ethylene oxide and/or propylene oxide units.
Patent DK-0473001-T3 (DK)
Inventor: GIEFER HEINZ-WERNER DIPL-ING
IPC: G05D7/01
Filed: 1991-08-13
Granted: 1995-05-01
Abstract: The device according to the invention has a housing (1) comprising a first, second and third housing part (11, 12, 13), the housing parts (11, 12, 13) being arranged directly following one another in the flow direction. The second (12) of the three housing parts (11, 12, 13) forms both a component of an outlet/shut-off valve (2) and a component of a fluid-flow control valve (3), in which a conduit is integrated between outlet/shut-off valve (2) and the fluid-flow control valve arranged immediately downstream in the flow direction. 
<IMAGE>
Patent DK-0471608-T3 (DK)
Inventor: DEMAREZ PHILIPPE
IPC: C21D8/02
Filed: 1991-08-06
Granted: 1996-12-23
Abstract: According to this method, the metal is solidified in a continuous-casting ingot mould consisting of two cooled rolls (2) rotating in opposite directions and arranged opposite each other so as to define a casting space between them, a solidified steel strip (3) is extracted continuously from the ingot mould, and, under the ingot mould, the said strip is subjected to a quenching medium (6) in order to cool it sufficiently rapidly in order to prevent the formation of austenite. This medium may consist of a quenching bath, placed in a container (4) arranged under the rolls (2), and whose bottom is pierced with an opening (5) for the passage of the solidified strip (3). It may also consist of an inert gas in the liquid state sprayed onto the product by nozzles. The steel strips obtained are easier to trim and to coil on exit from the casting line, by virtue of the absence of martensite in the ferritic matrix. 
<IMAGE>
Patent DK-0521070-T3 (DK)
Inventor: ACKERMAN ERIC WILLEM
IPC: A61K9/00
Filed: 1991-03-20
Granted: 1995-05-22
Abstract: The present invention relates to an aqueous suspension preparation for injection and to a method for producing the same and further relates to the use of said preparation for producing pain relief. The invention particularly relates to a preparation as indicated hereinabove, comprising a water-insoluble local anesthetic and/or narcotic analgesic suspended in an aqeuous medium, which preparation can be succesfully used for epidural and intrathecal pain relief and for conduction anesthesia and infiltration anesthesia. The preparation is stabilized by the addition of a non-ionic surface-active agent in an amount of less than 1 wt. %. The particles of the water-insoluble active agent have a mean particle diameter of less than 20  mu m. More than 99% of the particles have a diameter of less than 100  mu m and more than 90% have a diameter of less than 50  mu m.
Patent DK-0541646-T3 (DK)
Inventor: HERON KENNETH HARRY
IPC: H04R1/02
Filed: 1991-07-26
Granted: 1995-03-20
Abstract: A panel-form loudspeaker has a resonant multi-mode radiator panel which is excited at frequencies above the fundamental frequency and the coincidence frequency of the panel to provide high radiation efficiency through multi-medal motions within the panel, in contrast to the pistonic motions required of conventional loudspeakers. The radiator panel is a skinned composite with a honeycomb or similar core and must be such that it has a ratio of bending stiffness to the third power of panel mass per unit area (in mks units) of at least 10 and preferably at least 100. An aluminium skinned, aluminium honeycomb cored composite can meet this more severe criterion easily.   <IMAGE>
Patent DK-0557922-T3 (DK)
Inventor: STRUEWING JOHN W
IPC: C02F3/30
Filed: 1993-02-22
Granted: 1999-02-15
Abstract: An improved method and apparatus 10 for treating liquor containing biodegradable wastes wherein the liquor is first delivered to a quiescent primary settling zone 20 and then to an aeration zone. The aerated liquor is delivered downwardly through a column of submerged fixed media 30 having a high surface area to volume ratio so that aerobic microorganisms can grow on their surface. The liquor is recirculated through the aeration zone and fixed media 30, and is withdrawn from the unit after treatment. A portion of the aerated liquor from the top of the fixed media is recycled back into the primary settling zone to denitrify the nitrate rich aerated liquor by deoxygenating the dissolved nitrates and to equalize the BOD load in the secondary aerobic treatment zone. <IMAGE>
Patent DK-0579347-T3 (DK)
Inventor: NERLICH BIRGIT DR
IPC: A61K9/16
Filed: 1993-06-29
Granted: 1996-08-12
Abstract: The microencapsulation of water-soluble active ingredients using the principle of phase separation comprises (a) preparing a soln. of a biocompatible polymer in an organic solvent; (b) adding an aq. soln. or dispersion of one or more active ingredients to the soln. from (a); (c) adding a coacervation agent to the emulsion or dispersion from (b); (d) adding the mixt. from (c) to excess hardening agent which is a natural or synthetic ester of satd. 4-18C carboxylic acids and polyvalent alcohols; and (e) collecting and washing the microcapsules.
Patent DK-0576649-T3 (DK)
Inventor: MEYER GABRIEL
IPC: A61M11/00
Filed: 1993-01-21
Granted: 1996-08-05
Abstract: PCT No. PCT/CH93/00014 Sec. 371 Date Oct. 18, 1993 Sec. 102(e) Date Oct. 18, 1993 PCT Filed Jan. 21, 1993 PCT Pub. No. WO93/13737 PCT Pub. Date Jul. 22, 1993.The device represented in its storage position contains essentially a body (11) in synthetic material containing a reservoir (10) containing a medicinal substance (29). The body (11) is fitted with an applicator nozzle (15). The reservoir (10) has the shape of a cylindrical glass jacket (17) closed at one end by a movable sealing plug (18) and at the other end by a mobile piston (19). The mobile piston is linked with a plunger (16) which advantageously is a spring in a synthetic material. A flow rate controlling filter (19) is lodged in the applicator nozzle (15). This device is advantageous because the reservoir can be sterilized with its contents. The filter and the piston along with the plunger guarantee the medicinal substance remains in an aseptic state by preventing contamination via the applicator nozzle.
Patent DK-0633844-T3 (DK)
Inventor: LANKIN ROBERT
IPC: H02P7/298
Filed: 1993-03-30
Granted: 1999-12-27
Abstract: Optimal constructions for two motor/controller configurations are disclosed. The controller structure includes an H-bridge for controlling field current using synchronous-rectification of MOSFET devices, and a circuit for chopping the armature current using synchronous-rectification of MOSFET devices arranged in a half bridge. The controller may be configured with a series-wound or a separately excited DC traction motor. In the series-wound motor/controller configuration, the field and the armature current are separately controlled. In the separately excited motor/controller configuration, the field of the motor is preferably wound so that the rated field current is achieved at about 20% of the rated battery voltage. This provides a separately excited motor in which the field current can be boosted by a factor of 5 to achieve high start-up and low speed torques which match the torque outputs of a series-wound motor under similar operating conditions.
Patent DK-0648115-T3 (DK)
Inventor: BESEMER ARIE CORNELIS
IPC: A61K9/26
Filed: 1993-07-02
Granted: 1997-06-02
Abstract: PCT No. PCT/NL93/00138 Sec. 371 Date Feb. 15, 1995 Sec. 102(e) Date Feb. 15, 1995 PCT Filed Jul. 2, 1993 PCT Pub. No. WO94/01091 PCT Pub. Date Jan. 20, 1994In a composition for delayed release of an active substance, the active substance is incorporated in a polysaccharide matrix which consists of an essentially crystalline straight-chain glucan and contains a glucan-degrading agent. The glucan is in particular an  alpha -glucan which has essentially a helix structure. The glucan-degrading agent is preferably  alpha -amylase. The composition can contain high-molecular materials such as proteins, allergens, vaccine substances and microorganisms, and preferably has the form of compressed tablets.
Patent DK-0614736-T3 (DK)
Inventor: SISLEGARD LARS-OTTO
IPC: B30B15/16
Filed: 1994-02-12
Granted: 1996-08-05
Abstract: An arrangement for controlling the thickness of board products (4) during the pressing process in a board press with a first and a second press table (5,2) where the pressing force is transferred by several hydraulic press cylinders (1). A number of hydraulic position valves (7) are arranged in spaced relationship on both sides of the press on the first press table (5). Corresponding push-rods (9) are arranged on the second press table (2). The push-rods are adjustable, and a common shifting motor (12) is provided for simultaneous adjustment of the push-rods (9). <IMAGE>
Patent DK-0659762-T3 (DK)
Inventor: CHAKI HARUYUKI
IPC: C07J17/00
Filed: 1994-12-23
Granted: 1998-10-19
Abstract: Sialic acid derivatives represented by the general formula (I): <CHEM>  wherein R<1> is a steroidal compound residue;  R<2> is H or alkyl;  R<3> is alkyl; <CHEM> wherein each of R<6> and R<7> is H, alkyl or the like and I is an integer of 0 to 6; or the like;     X is O or S; R<4> is H or acyl; and R<5> is R<1><4>O- (R<1><4> is H or acyl) or R<1><5>NH-(R<1><5> is acyl or the like);     their salts, hydrates or solvates are provided. Sialic acid derivatives of the present invention are expected to be effective medicines for the prevention and therapy of senile dementia including Alzheimer's disease and the like, because they increase ChAT activity in cholinergic neurons.
Patent DK-0679582-T3 (DK)
Inventor: WALKER LINDA A
IPC: B65D55/02
Filed: 1995-01-23
Granted: 1999-08-09
Abstract: The bottle has a neck defining an opening at one end and a body having a recessed portion at the end opposite the opening. The recessed portion has a plurality of ramps disposed about its perimeter, the bottle having a thread disposed on the neck. A press-and-turn type cap has an inner shell engageable with the thread and an outer shell engaging with the inner shell by a press-and-turn device. The outer shell having a plurality of ramps disposed about the perimeter of the side. The ramps are disposed on the cap facing opposite the ramps disposed on the bottle. The ramps on the cap face in a counterclockwise direction and ramps on the bottle face in a clockwise direction. The bottle is cylindrical. The ramps are completely disposed about the perimeter of the bottle and cap and are intermittently disposed about the perimeter of the bottle and cap.
Patent DK-0741693-T3 (DK)
Inventor: ZIEGLER HUGO
IPC: C07C249/12
Filed: 1995-01-16
Granted: 1999-10-11
Abstract: PCT No. PCT/EP95/00146 Sec. 371 Date Jul. 22, 1996 Sec. 102(e) Date Jul. 22, 1996 PCT Filed Jan. 16, 1995 PCT Pub. No. WO95/20569 PCT Pub. Date Aug. 3, 1995Process for the preparation of 2-methoxyimino-2-arylacetic esters of formula (I) in which R is C1-C12alkyl, which comprises reacting an appropriately substituted boronic acid of general formula (II) or the trimeric form (lII) herein, which is in equilibrium with it, in the presence of a Pd catalyst, with a methoxyiminoacetic ester of formula (IV) in which R is C1-C12alkyl and X is a leaving group. According to a further process variant, in principle the groups which split off the two reactants may change places. The process can be applied not only to phenyl derivatives but also to larger ring systems (naphthyl, pyridyl, heterocycles).
Patent DK-0755399-T3 (DK)
Inventor: KUTSCHER BERNHARD
IPC: A61K31/28
Filed: 1995-03-31
Granted: 2000-03-27
Abstract: Cis-[trans-1,2-cyclobutanebis (methylamine)-N,N']-[(2S)-lactate-O1,O2)-platinum (II) trihydrate (lobaplatin trihydrate) and its preparation.
Patent DK-0777653-T3 (DK)
Inventor: ITO FUMITAKA
IPC: A61K31/4427
Filed: 1995-05-26
Granted: 2001-10-08
Abstract: PCT No. PCT/IB95/00400 Sec. 371 Date Jul. 1, 1997 Sec. 102(e) Date Jul. 1, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO96/06082 PCT Pub. Date Feb. 29, 1996Compound of formula (1) and their pharmaceutically acceptable salts wherein A1,A2,R1, R2,R3,R4,X are as defined in the specification have excellent bradykinin antagonistic activity.    <IMAGE>  (I)
Patent DK-0774005-T3 (DK)
Inventor: SPRINGER CAROLINE JOY
IPC: A61K38/46
Filed: 1995-07-27
Granted: 2000-05-22
Abstract: The invention provides a two component system for use in association with one another comprising:   (a) a vector capable of expressing an enzyme at the surface of a cell; and (b) a prodrug which can be converted into an active drug by said enzyme, useful in the treatment of tumours.
Patent DK-0801559-T3 (DK)
Inventor: VAN KOUTRIK ROBERTUS CORNELIS
IPC: A61K31/545
Filed: 1996-02-08
Granted: 2002-06-17
Abstract: PCT No. PCT/EP96/00547 Sec. 371 Date Aug. 6, 1997 Sec. 102(e) Date Aug. 6, 1997 PCT Filed Feb. 8, 1996 PCT Pub. No. WO96/24337 PCT Pub. Date Aug. 15, 1996A granulate, containing at least 50 wt. % of a water soluble  beta -lactam antibiotic, is provided. A process to prepare a granulate containing such  beta -lactam antibiotic comprises moistening components making up the granulate with an aqueous solution containing no substantial amount of a wet granulation binding agent. Oral dosage-forms, which contain the said antibiotic in a granular form, a cellulose product and a disintegrant and which quickly disperse when placed in an aqueous environment, are disclosed, as well as a method for the preparation of the dosage-forms.